Increased rate of pancreatitis in gender diverse and transgender patients on hormone therapy: a case series study.
BMJ Open Gastroenterol
; 11(1)2024 Apr 22.
Article
in En
| MEDLINE
| ID: mdl-38653505
ABSTRACT
BACKGROUND:
There is limited data on the incidence of gastrointestinal-specific pathology in gender non-conforming (GNC) populations.METHODS:
Retrospective analysis of pancreatitis incidence rates in transgender and GNC persons exposed and not exposed to gender-affirming hormone therapy (GAHT).RESULTS:
7 of the 1333 patients on hormone therapy had an incidence of pancreatitis. 0 of the 615 patients with no history of GAHT use developed pancreatitis. Representing a 6.96 (95% CI 2.76 to 848.78) for the development of pancreatitis in patients with exposure to GAHT therapy.CONCLUSION:
Clinicians working with GNC individuals should be aware of this possible association.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatitis
/
Transgender Persons
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BMJ Open Gastroenterol
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: